Literature DB >> 18718219

Aggressive hepatic resection for patients with pyogenic liver abscess and APACHE II score > or =15.

Huan-Fa Hsieh1, Teng-Wei Chen, Chih-Yung Yu, Ning-Chi Wang, Heng-Cheng Chu, Ming-Liang Shih, Jyh-Cherng Yu, Chung-Bao Hsieh.   

Abstract

BACKGROUND: Most liver abscesses resolve after antimicrobial therapy or percutaneous tube drainage (PD). The aim of this study was to evaluate the results of hepatic resection (HR) for patients with pyogenic liver abscesses and an Acute Physiology and Chronic Health Evaluation II (APACHE II) score > or =15.
METHODS: We compared the clinical outcomes of 81 patients with APACHE II scores > or =15 undergoing PD and/or HR.
RESULTS: The failure rate (3 of 65) and double-treatment rate (32 of 65) in the PD group were significantly higher than in the HR group (3 of 35 vs 0 of 35; P = .0002). The mortality rate in the PD group was significantly higher than the other 2 groups (14 of 46 vs 2 of 19 and 1 of 16; P = .038). The length of hospital stay was significantly shorter and antibiotic use less in the HR group than in the PD group (P < .05).
CONCLUSIONS: Aggressive HR for patients with liver abscesses and APACHE II scores > or =15 produced better clinical outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18718219     DOI: 10.1016/j.amjsurg.2007.09.051

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

1.  A new interventional technique for percutaneous treatment of drainage-resistant liver abscess.

Authors:  K P De Jong; T R Prins; H S Hofker
Journal:  Br J Radiol       Date:  2010-09       Impact factor: 3.039

2.  Pyogenic liver abscess: differences in etiology and treatment in Southeast Asia and Central Europe.

Authors:  Herwig Cerwenka
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

Review 3.  Hypervirulent Klebsiella pneumoniae.

Authors:  Thomas A Russo; Candace M Marr
Journal:  Clin Microbiol Rev       Date:  2019-05-15       Impact factor: 26.132

4.  Synchronous pyogenic liver abscess and acute cholecystitis: how to recognize it and what to do (emergency cholecystostomy followed by delayed laparoscopic cholecystectomy).

Authors:  Renato Costi; Alban Le Bian; François Cauchy; Papa Saloum Diop; Alessio Carloni; Laurence Catherine; Claude Smadja
Journal:  Surg Endosc       Date:  2011-08-20       Impact factor: 4.584

5.  Klebsiella pneumoniae invasive liver abscess syndrome with purulent meningitis and septic shock: A case from mainland China.

Authors:  Yun Qian; Chi-Chun Wong; San-Chuan Lai; Zheng-Hua Lin; Wei-Liang Zheng; Hui Zhao; Kong-Han Pan; Shu-Jie Chen; Jian-Min Si
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

6.  Survival after intestinal perforation: can it be predicted?

Authors:  Celestine S Tung; Charlotte C Sun; Matthew P Schlumbrecht; Larissa A Meyer; Diane C Bodurka
Journal:  Gynecol Oncol       Date:  2009-09-18       Impact factor: 5.482

7.  Broadening of the red blood cell distribution width is associated with increased severity of illness in patients with sepsis.

Authors:  Nader A Mahmood; Jacob Mathew; Balwinder Kang; Vincent A DeBari; Muhammad Anees Khan
Journal:  Int J Crit Illn Inj Sci       Date:  2014 Oct-Dec

8.  Resection of a methicillin-resistant Staphylococcus aureus liver abscess in a patient with Crohn's disease under infliximab treatment: a case report.

Authors:  Junichi Togashi; Yasuhiko Sugawara; Nobuhisa Akamatsu; Taku Aoki; Masayoshi Ijichi; Mami Tanabe; Koji Kusaka; Masayuki Shibazaki; Tokuma Tadami; Minako Sakou; Masakazu Takazoe; Yasutsugu Bandai; Norihiro Kokudo
Journal:  J Med Case Rep       Date:  2013-02-01

Review 9.  Therapy of Liver Abscesses.

Authors:  Christoph Lübbert; Johannes Wiegand; Thomas Karlas
Journal:  Viszeralmedizin       Date:  2014-10

10.  Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice.

Authors:  Golnar Karimian; Marc Kirschbaum; Zwanida J Veldhuis; Fernanda Bomfati; Robert J Porte; Ton Lisman
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.